Lanadelumab (SHP643)

Lanadelumab · Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lanadelumab (SHP643), covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE) [Phase 3]